Infectious Diseases
Latest News
Texas district court allows employers to deny HIV PrEP coverage
"Judge O'Connor has a long history of issuing rulings against the Affordable Care Act and LGBT individuals, and we expect the case to be...
From the Journals
Influenza vaccine may offer much more than flu prevention
“There are some pieces of evidence that suggest influenza vaccination may release anti-inflammatory mediators that can stabilize the atheroma...
From the Journals
Unvaccinated 10 times more likely to be hospitalized for Omicron
Vaccinated, hospitalized patients were more often older and already dealing with other health conditions, a new study finds.
From the Journals
Acute myocarditis a possible complication of monkeypox
“This case highlights cardiac involvement as a potential complication associated with monkeypox infection.”
From the Journals
Dolutegravir in pregnant patients with HIV showed more viral suppression at delivery vs. other treatments
Dolutegravir-based ART yields similar birth outcomes to other ART options.
From the Journals
Consensus document aids schistosomiasis management
Pilot studies point to a high rate of underdiagnosis.
From the Journals
AHA guidance on infective endocarditis with injection drug use
Managing IE in people who inject drugs is complex and requires a unique multidisciplinary approach.
Feature
Asymptomatic infections drive many epidemics, including monkeypox, polio, and COVID
“I think 80% of [COVID] transmissions are done by 20% of infected people because those are the ones who are shedding the most virus.”
Latest News
U.S. life expectancy drops to lowest in decades
“Even small declines in life expectancy of a tenth or two-tenths of a year mean that on a population level, a lot more people are dying...
Feature
Many young kids with COVID may show no symptoms
The relationship between symptoms and viral load also differed between adults and young children in a new study.
News
FDA authorizes updated COVID boosters to target newest variants
The agency cited data to support the safety and efficacy of this next generation of mRNA vaccines targeted toward variants of concern.